Hudson Bay Capital Management »

Miragen Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $766k 35k 21.78

More positions owned by Hudson Bay Capital Management

Amazon Call Option (AMZN)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Meta Platforms Cl A Put Option (META)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
NVIDIA Corporation Put Option (NVDA)
salesforce Put Option (CRM)
Select Sector Spdr Tr Financial (XLF)
Adobe Systems Incorporated Put Option (ADBE)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Miragen Therapeutics

Paradigm Biocapital Advisors
VR Adviser
Vanguard Group
Maverick Capital
Alliancebernstein
Commodore Capital
Perceptive Advisors
Vivo Capital
Fairmount Funds Management
Yiheng Capital
Citadel Advisors
Tang Capital Management
Octagon Capital Advisors
Kynam Capital Management
Logos Global Management

View all funds holding Miragen Therapeutics